Please check your internet connection and try again.
# Lorazepam (representative benzodiazepine)
## Overview
Lorazepam is a short-acting benzodiazepine used for its sedative, anxiolytic, hypnotic, and anticonvulsant properties. It enhances the inhibitory effects of gamma-aminobutyric acid (GABA) in the central nervous system.
## Primary Indications
* Anxiety disorders
* Insomnia due to anxiety or transient situational stress
* Seizure management (status epilepticus)
* Premedication for surgical procedures
* Sedation in critically ill patients
## Adult Dosing
* **Anxiety:** 0.5 mg to 2 mg orally every 6 to 8 hours. Maximum dose typically 10 mg daily, but may vary by indication and patient.
* **Insomnia:** 2 mg to 4 mg orally at bedtime.
* **Status Epilepticus:** 4 mg intramuscularly or intravenously. May repeat in 10-15 minutes if seizure persists. Maximum dose of 8 mg in a 12-hour period.
* **Premedication:** 2 mg to 4 mg orally or intramuscularly 2 hours before surgery.
* **Intensive Care Unit (ICU) Sedation:** Initial dose 1 mg to 4 mg intravenously. Maintenance infusion may be initiated, but titrate to desired level of sedation.
## Pediatric Dosing
Dosing in pediatric patients is less established and should be determined by weight and clinical response. Close monitoring is essential.
* **Seizure Management:** 0.05 mg/kg intravenously or intramuscularly, not to exceed 4 mg per dose. May repeat in 10-15 minutes.
* **Sedation:** Dosing varies significantly. Consultation with pediatric critical care specialists is recommended.
## Dose Adjustments
* **Hepatic Impairment:** Use with caution; dose reduction may be necessary.
* **Renal Impairment:** No specific dose adjustment recommended, but use with caution.
* **Elderly:** Initiate at lower doses (e.g., 0.5 mg twice daily) due to increased sensitivity and risk of side effects like sedation and falls.
## Contraindications
* Known hypersensitivity to benzodiazepines or any component of the formulation.
* Acute narrow-angle glaucoma.
* Severe respiratory insufficiency (unless used for status epilepticus).
* Severe hepatic insufficiency (unless used for status epilepticus).
* Sleep apnea syndrome.
## Adverse Effects
Common adverse effects include drowsiness, dizziness, weakness, unsteadiness, and fatigue. Less common include confusion, depression, amnesia, and paradoxical reactions (agitation, hallucinations). Respiratory depression is a serious concern, especially with IV administration or in combination with other CNS depressants.
## Key Drug Interactions
* **CNS Depressants (opioids, alcohol, barbiturates, other sedatives):** Potentiates CNS depression, leading to increased sedation, respiratory depression, coma, and death. Use together cautiously, with the lowest effective doses and shortest duration of treatment.
* **Theophylline/Aminophylline:** May reduce the sedative effects of lorazepam.
* **Valproic Acid:** May increase lorazepam plasma concentrations.
## Monitoring
* Level of sedation and respiratory status.
* Signs of paradoxical reactions.
* Signs of withdrawal upon discontinuation.
* For prolonged use, monitor for dependence.
## Clinical Pearls
* Lorazepam has a relatively short half-life compared to some other benzodiazepines, which may lead to more frequent dosing but potentially less accumulation in the elderly.
* Avoid abrupt discontinuation due to the risk of withdrawal symptoms (anxiety, insomnia, seizures). Tapering is recommended.
* Intravenous administration can cause hypotension and respiratory depression. Have resuscitation equipment readily available.
* The oral formulation is effective for anxiolysis and as a pre-anesthetic.
***
*This information is intended for clinical pharmacists and prescribers. Always consult the current prescribing information and institutional protocols for complete and up-to-date guidance.*
